Title : Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.

Pub. Date : 2004 Jan

PMID : 14697899






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The consequence of these findings were the development of reversible MAO-A inhibitors (RIMA), moclobemide and brofaromin, as antidepressants and possible anti-Parkinson activity, with limited tyramine potentiation, since the amine can displace the inhibitor from its binding site on the enzyme. Amines monoamine oxidase A Homo sapiens